Avenanthramide C triggered cellular senescence in colon cancer cells by inhibiting the β-catenin-mediated transcription of miR-183/96/182 cluster, which was shown to be associated with the up-regulation of FOXO3 [119]. Here, FOXO3 is linked to malignant colon neoplasm.